tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
uniQure Announces Positive Results for Huntington’s Study
PremiumCompany AnnouncementsuniQure Announces Positive Results for Huntington’s Study
1M ago
uniQure Secures $175 Million Loan Amendment
Premium
Company Announcements
uniQure Secures $175 Million Loan Amendment
1M ago
uniQure’s Promising Advancements in Huntington’s Disease Treatment and Strong Financial Position Justify Buy Rating
Premium
Ratings
uniQure’s Promising Advancements in Huntington’s Disease Treatment and Strong Financial Position Justify Buy Rating
1M ago
uniQure price target raised to $65 from $30 at Stifel
PremiumThe FlyuniQure price target raised to $65 from $30 at Stifel
1M ago
uniQure’s AMT-130 Gene Therapy Shows Promising Results in Huntington’s Disease Trials, Justifying Buy Rating and $70 Price Target
Premium
Ratings
uniQure’s AMT-130 Gene Therapy Shows Promising Results in Huntington’s Disease Trials, Justifying Buy Rating and $70 Price Target
1M ago
uniQure has leading candidate in Huntington’s, says H.C. Wainwright
Premium
The Fly
uniQure has leading candidate in Huntington’s, says H.C. Wainwright
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100